Pragmatic reappraisal of long-acting muscarinic antagonists at steps 4 and 5 for persistent adult asthma.
作者信息
Lipworth Brian, Stewart Kirsten E, Chan Rory
机构信息
Scottish Centre for Respiratory Research, Ninewells Hospital and Medical School, University of Dundee, Dundee, Scotland, United Kingdom.
Scottish Centre for Respiratory Research, Ninewells Hospital and Medical School, University of Dundee, Dundee, Scotland, United Kingdom.
出版信息
Ann Allergy Asthma Immunol. 2022 Sep;129(3):274-275. doi: 10.1016/j.anai.2022.05.017. Epub 2022 May 22.
PMID:35613664
Abstract
摘要
相似文献
1
Pragmatic reappraisal of long-acting muscarinic antagonists at steps 4 and 5 for persistent adult asthma.
Ann Allergy Asthma Immunol. 2022 Sep;129(3):274-275. doi: 10.1016/j.anai.2022.05.017. Epub 2022 May 22.
2
New and developing non-adrenoreceptor small molecule drugs for the treatment of asthma.用于治疗哮喘的新型及正在研发的非肾上腺素能受体小分子药物。
Expert Opin Pharmacother. 2017 Feb;18(3):283-293. doi: 10.1080/14656566.2017.1284794. Epub 2017 Feb 1.
3
Tiotropium bromide as add-on therapy to inhaled corticosteroids for treating asthma.噻托溴铵作为吸入性糖皮质激素的附加疗法用于治疗哮喘。
Expert Opin Pharmacother. 2015 Jun;16(9):1403-9. doi: 10.1517/14656566.2015.1045877.
4
Managing Severe Asthma: A Role for the Long-Acting Muscarinic Antagonist Tiotropium.管理严重哮喘：长效毒蕈碱拮抗剂噻托溴铵的作用。
Biomed Res Int. 2018 Oct 24;2018:7473690. doi: 10.1155/2018/7473690. eCollection 2018.
5
Tiotropium – what role in asthma?噻托溴铵——在哮喘中起什么作用？
Drug Ther Bull. 2015 Sep;53(9):102-4. doi: 10.1136/dtb.2015.9.0349.
6
Anticholinergics for asthma: a long history.用于治疗哮喘的抗胆碱能药物：悠久的历史。
Curr Opin Allergy Clin Immunol. 2018 Feb;18(1):38-43. doi: 10.1097/ACI.0000000000000408.
7
Role of muscarinic antagonists in asthma therapy.毒蕈碱拮抗剂在哮喘治疗中的作用。
Expert Rev Respir Med. 2017 Mar;11(3):239-253. doi: 10.1080/17476348.2017.1289844. Epub 2017 Feb 9.
8
The reality of LAMAs for adult asthmatic patients.长效抗胆碱能药物在成年哮喘患者中的现实情况。
Expert Rev Respir Med. 2020 Nov;14(11):1087-1094. doi: 10.1080/17476348.2020.1794828. Epub 2020 Jul 20.
9
Time to Converge FDA Decisions and Evidence Syntheses for Long-Acting Muscarinic Antagonists and SMART in Guidelines for the Treatment of Asthma.统一美国食品药品监督管理局关于长效毒蕈碱拮抗剂的决策和证据合成以及将其纳入哮喘治疗指南中的SMART的时机。
JAMA. 2018 Apr 10;319(14):1441-1443. doi: 10.1001/jama.2018.2029.
10
Tiotropium in the management of paediatric and adolescent asthma: Systematic review.噻托溴铵治疗儿童和青少年哮喘的管理：系统评价。
Paediatr Respir Rev. 2021 Jun;38:58-62. doi: 10.1016/j.prrv.2020.08.003. Epub 2020 Aug 25.
Zotero 插件